Could Mind Medicine Be a Millionaire-Maker Stock?

As outlandish as it sounds, psychedelic chemicals like LSD might be the wonder drugs of the near future. If you're a skeptic, consider that a growing body of research over the last couple of decades has shown that psychedelics have the potential to help people with common but difficult-to-treat mental illnesses like depression and addiction. And where there's a way to improve over the existing solutions, there's money to be made.

That's where the psychedelic biotech Mind Medicine (NASDAQ: MNMD) comes in. The company has several therapy programs in development, all of which aim to leverage the latest research and biotechnology innovations to make psychiatric medicines that have never been commercialized before. Could the stock make its early investors into millionaires, or is it just another biotech that's having a moment before flaring out?

Image source: Getty Images.

Source Fool.com